Marvell president’s trust sells 10,000 shares

Marvell Technology, Inc. reported an insider stock sale by a family trust associated with its President and COO, Chris Koopmans.

Rhea-AI Filing Summary

Marvell Technology, Inc. reported an insider stock sale by a family trust associated with its President and COO, Chris Koopmans. The Christopher R. Koopmans and Heather J. Koopmans Family Trust sold 10,000 shares of Marvell common stock in an open-market transaction at a weighted average price of $205.87 per share. According to the filing, the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 5, 2026. After this transaction, the trust continues to hold 237,392 Marvell shares indirectly for Koopmans.

Insights

Equity analyst

Pre-planned trust sale of 10,000 Marvell shares; sizable indirect stake remains.

The transaction shows a family trust linked to Marvell’s President and COO selling 10,000 common shares in the open market at a weighted average price of $205.87. This is an indirect holding, reported as "By Trust" rather than personal direct ownership.

The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on January 5, 2026, suggesting it was scheduled in advance rather than timed opportunistically. Such plans are commonly used to diversify or manage liquidity while reducing concerns about trading on nonpublic information.

After the sale, the family trust still holds 237,392 shares, so most of the indirect position remains in place. Subsequent company filings may provide further context if additional 10b5-1 plan sales occur or if there are changes to the executive’s overall equity exposure.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Koopmans Chris

Role President and COO

Sold 10,000 shs ($2.06M)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$205.87	$2.06M

Holdings After Transaction: Common Stock — 237,392 shares (Indirect, By Trust)

Footnotes (3)

1. F1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.
2. F2. The price reported is a weighted average price rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $195.51 to $211.87, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
3. F3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Key Figures

Shares sold: 10,000 shares Average sale price: $205.87 per share Post-transaction holdings: 237,392 shares +1 more

4 metrics

Shares sold 10,000 shares Open-market sale on June 1, 2026

Average sale price $205.87 per share Weighted average for the reported sale

Post-transaction holdings 237,392 shares Indirectly held by family trust after sale

Sale price range $195.51–$211.87 per share Multiple trades within this range

Key Terms

Rule 10b5-1 Plan, weighted average price, Family Trust, open-market sale

4 terms

Rule 10b5-1 Plan regulatory

"Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average price financial

"The price reported is a weighted average price rounded to the nearest cent."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Family Trust financial

"Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust."

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marvell Technology (MRVL) report in this Form 4?

Marvell Technology (MRVL) reported that a family trust linked to President and COO Chris Koopmans sold 10,000 shares of common stock in an open-market transaction. The sale was executed at a weighted average price of $205.87 per share across multiple trades within a disclosed price range.

Who actually sold the Marvell (MRVL) shares reported in this filing?

The seller was the Christopher R. Koopmans and Heather J. Koopmans Family Trust, which holds shares indirectly for executive Chris Koopmans. The Form 4 lists ownership as "By Trust," meaning the transaction is attributed to the trust rather than direct personal holdings by Koopmans himself.

How many Marvell (MRVL) shares does the Koopmans family trust hold after the sale?

Following the reported open-market sale of 10,000 shares, the Christopher R. Koopmans and Heather J. Koopmans Family Trust now holds 237,392 shares of Marvell common stock. This reflects the remaining indirect equity stake associated with President and COO Chris Koopmans after the disclosed transaction.

At what prices were the Marvell (MRVL) shares sold in this insider trade?

The filing shows a weighted average sale price of $205.87 per Marvell share. Footnotes explain the shares were sold in multiple transactions at prices ranging from $195.51 to $211.87, and full trade detail is available from the company or regulators upon request.

Was the Marvell (MRVL) insider sale made under a Rule 10b5-1 trading plan?

Yes. The footnotes state the sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2026. Such pre-arranged plans schedule trades in advance and are commonly used to manage insider sales more systematically.

Does this Marvell (MRVL) Form 4 show any option exercises or derivative transactions?

No. The reported activity involves only non-derivative common stock sales. The derivative section of the filing is empty, and the transaction summary lists zero derivative exercises, conversions, or other derivative transactions associated with this particular Form 4 event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 08:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CALIFORNIA 95054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)		10,000	D	$205.87(2)	237,392	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.

2. The price reported is a weighted average price rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $195.51 to $211.87, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)